TY - JOUR
T1 - Characteristics of deaths associated with kratom use
AU - Corkery, John
AU - Streete, Peter
AU - Claridge, Hugh
AU - Goodair, Christine
AU - Papanti, Duccio G.
AU - Orsolini, Laura
AU - Schifano, Fabrizio
AU - Sikka, Kanav
AU - Körber, Sophie
AU - Hendricks, Amy
N1 - Submitted on 15 February 2019. Reviewers’ comments received 10 May 2019. Revision accepted 17 June 2019. Published early online 20 August 2019. Published with Volume, etc. 5 September 2019.
PY - 2019/9/1
Y1 - 2019/9/1
N2 - Background: Kratom (Mitragyna speciosa Korth) use has increased in Western countries, with a rising number of associated deaths. There is growing debate about the involvement of kratom in these events. Aims: This study details the characteristics of such fatalities and provides a ‘state-of-the-art’ review. Methods: UK cases were identified from mortality registers by searching with the terms ‘kratom’, ‘mitragynine’, etc. Databases and online media were searched using these terms and ‘death’, ‘fatal*’, ‘overdose’, ‘poisoning’, etc. to identify additional cases; details were obtained from relevant officials. Case characteristics were extracted into an Excel spreadsheet, and analysed employing descriptive statistics and thematic analysis. Results: Typical case characteristics (n = 156): male (80%), mean age 32.3 years, White (100%), drug abuse history (95%); reasons for use included self-medication, recreation, relaxation, bodybuilding, and avoiding positive drug tests. Mitragynine alone was identified/implicated in 23% of cases. Poly substance use was common (87%), typically controlled/recreational drugs, therapeutic drugs, and alcohol. Death cause(s) included toxic effects of kratom ± other substances; underlying health issues. Conclusions: These findings add substantially to the knowledge base on kratom-associated deaths; these need systematic, accurate recording. Kratom’s safety profile remains only partially understood; toxic and fatal levels require quantification.
AB - Background: Kratom (Mitragyna speciosa Korth) use has increased in Western countries, with a rising number of associated deaths. There is growing debate about the involvement of kratom in these events. Aims: This study details the characteristics of such fatalities and provides a ‘state-of-the-art’ review. Methods: UK cases were identified from mortality registers by searching with the terms ‘kratom’, ‘mitragynine’, etc. Databases and online media were searched using these terms and ‘death’, ‘fatal*’, ‘overdose’, ‘poisoning’, etc. to identify additional cases; details were obtained from relevant officials. Case characteristics were extracted into an Excel spreadsheet, and analysed employing descriptive statistics and thematic analysis. Results: Typical case characteristics (n = 156): male (80%), mean age 32.3 years, White (100%), drug abuse history (95%); reasons for use included self-medication, recreation, relaxation, bodybuilding, and avoiding positive drug tests. Mitragynine alone was identified/implicated in 23% of cases. Poly substance use was common (87%), typically controlled/recreational drugs, therapeutic drugs, and alcohol. Death cause(s) included toxic effects of kratom ± other substances; underlying health issues. Conclusions: These findings add substantially to the knowledge base on kratom-associated deaths; these need systematic, accurate recording. Kratom’s safety profile remains only partially understood; toxic and fatal levels require quantification.
KW - Mitragynine
KW - cause of death
KW - characteristics
KW - kratom
KW - toxicology
UR - http://www.scopus.com/inward/record.url?scp=85071493122&partnerID=8YFLogxK
U2 - 10.1177/0269881119862530
DO - 10.1177/0269881119862530
M3 - Article
SN - 0269-8811
VL - 33
SP - 1102
EP - 1123
JO - Journal of Psychopharmacology
JF - Journal of Psychopharmacology
IS - 9
ER -